Senolytics function by selectively inducing apoptosis in senescent cells while sparing normal cells. They target specific pathways that are upregulated in senescent cells, such as the BCL-2 family of anti-apoptotic proteins, which help these cells resist cell death. By inhibiting these pathways, senolytics can effectively clear senescent cells from tissues.
